 SEATTLE, Feb. 08, 2021 GLOBE NEWSWIRE -- Sana Biotechnology, Inc. Nasdaq: SANA, a company focused on creating and delivering engineered cells as medicines, today announced the closing of its upsized initial public offering of 27,025,000 shares of its common stock at a public offering price of 25.00 per share, which includes the full exercise by the underwriters of their option to purchase 3,525,000 additional shares of common stock. The aggregate gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Sana, were approximately 675.6 million. All of the shares of common stock were offered by Sana. Sanas common stock is listed on The Nasdaq Global Select Market under the ticker symbol SANA. 